Patents by Inventor Stewart WASHER

Stewart WASHER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230414559
    Abstract: The present invention relates to a method for treating a sleep disorder. Preferably, the invention relates to a method for treating a sleep disorder comprising the step of administering a pharmaceutical composition comprising a Cannabis extract and optionally one or more pharmaceutically acceptable carriers, diluents, adjuvants, excipients or any combination thereof, the Cannabis extract comprising a terpene fraction comprising limonene in an amount of at least about 5.4% by weight of the terpene fraction.
    Type: Application
    Filed: September 1, 2023
    Publication date: December 28, 2023
    Inventors: Harry KARELIS, Mara GORDON, Stewart SMITH, Stewart WASHER
  • Patent number: 11779562
    Abstract: The present invention relates to a method for treating a sleep disorder. Preferably, the invention relates to a method for treating a sleep disorder comprising the step of administering a pharmaceutical composition comprising a Cannabis extract and optionally one or more pharmaceutically acceptable carriers, diluents, adjuvants, excipients or any combination thereof, the Cannabis extract comprising a terpene fraction comprising limonene in an amount of at least about 5.4% by weight of the terpene fraction.
    Type: Grant
    Filed: July 14, 2022
    Date of Patent: October 10, 2023
    Assignee: Zelira Therapeutics Operations Pty Ltd
    Inventors: Harry Karelis, Mara Gordon, Stewart Smith, Stewart Washer
  • Publication number: 20230270808
    Abstract: The invention relates to a pharmaceutical composition comprising a Cannabis extract and optionally one or more pharmaceutically acceptable carriers, diluents, adjuvants, excipients or any combination thereof, the Cannabis extract comprising a cannabinoid fraction comprising ?9-Tetrahydrocannabinol (THC), Cannabidiol (CBD), and Cannabinol (CBN) and a terpene fraction in an amount of at least 3% by weight of the extract. The invention also relates to methods of treating sleep disorders using this pharmaceutical composition.
    Type: Application
    Filed: February 21, 2023
    Publication date: August 31, 2023
    Inventors: Mara GORDON, Stewart SMITH, Stewart WASHER, Patrizia WASHER, Harry KARELIS
  • Publication number: 20220362208
    Abstract: The invention relates to a method for treating a skin disorder. In particular, the invention provides a method for treating a skin disorder, comprising administering to a patient in need thereof an effective amount of the pharmaceutical composition comprising a Cannabis extract and optionally one or more pharmaceutically acceptable carriers, diluents, adjuvants, excipients or any combination thereof, the Cannabis extract comprising at least 75% by weight of a main cannabinoid.
    Type: Application
    Filed: July 28, 2022
    Publication date: November 17, 2022
    Inventors: Harry KARELIS, Mara GORDON, Stewart SMITH, Stewart WASHER
  • Publication number: 20220347155
    Abstract: The present invention relates to a method for treating a sleep disorder. Preferably, the invention relates to a method for treating a sleep disorder comprising the step of administering a pharmaceutical composition comprising a Cannabis extract and optionally one or more pharmaceutically acceptable carriers, diluents, adjuvants, excipients or any combination thereof, the Cannabis extract comprising a terpene fraction comprising limonene in an amount of at least about 5.4% by weight of the terpene fraction.
    Type: Application
    Filed: July 14, 2022
    Publication date: November 3, 2022
    Inventors: Harry KARELIS, Mara GORDON, Stewart SMITH, Stewart WASHER
  • Publication number: 20220202767
    Abstract: The invention relates to a method for treating cancer or a symptom associated with cancer. In particular, the present invention relates to a method for treating cancer or a symptom associated with cancer, comprising administering to a patient in need thereof an effective amount of the pharmaceutical composition comprising a Cannabis extract that comprises ?9-tetrahydrocannabinol (THC) in an amount of from 50% to 99% by weight of the pharmaceutical composition.
    Type: Application
    Filed: March 16, 2022
    Publication date: June 30, 2022
    Inventors: Harry KARELIS, Mara GORDON, Stewart SMITH, Stewart WASHER
  • Patent number: 11304925
    Abstract: The invention relates to a method for treating cancer or a symptom associated with cancer. In particular, the present invention relates to a method for treating cancer or a symptom associated with cancer, comprising administering to a patient in need thereof an effective amount of the pharmaceutical composition comprising a Cannabis extract that comprises ?9-tetrahydrocannabinol (THC) in an amount of from 50% to 99% by weight of the pharmaceutical composition.
    Type: Grant
    Filed: August 3, 2017
    Date of Patent: April 19, 2022
    Assignee: ZELDA THERAPEUTICS OPERATIONS PTY LTD
    Inventors: Harry Karelis, Mara Gordon, Stewart Smith, Stewart Washer
  • Publication number: 20210145910
    Abstract: The invention relates to a pharmaceutical composition comprising a Cannabis extract and optionally one or more pharmaceutically acceptable carriers, diluents, adjuvants, excipients or any combination thereof, the Cannabis extract comprising a cannabinoid fraction comprising ?9-Tetrahydrocannabinol (THC), Cannabidiol (CBD), and Cannabinol (CBN) and a terpene fraction in an amount of at least 3% by weight of the extract. The invention also relates to methods of treating sleep disorders using this pharmaceutical composition.
    Type: Application
    Filed: June 19, 2018
    Publication date: May 20, 2021
    Inventors: Mara GORDON, Stewart SMITH, Stewart WASHER, Patrizia WASHER, Harry KARELIS
  • Publication number: 20190307719
    Abstract: The invention relates to a method for treating a skin disorder. In particular, the invention provides a method for treating a skin disorder, comprising administering to a patient in need thereof an effective amount of the pharmaceutical composition comprising a Cannabis extract and optionally one or more pharmaceutically acceptable carriers, diluents, adjuvants, excipients or any combination thereof, the Cannabis extract comprising at least 75% by weight of a main cannabinoid.
    Type: Application
    Filed: August 3, 2017
    Publication date: October 10, 2019
    Inventors: Harry KARELIS, Mara GORDON, Stewart SMITH, Stewart WASHER